ライフサイエンスコーパス: Candida tropicalis

1 rker in clinical isolates of C. albicans and Candida tropicalis.

2 photericin B killed amphotericin B-resistant Candida tropicalis.

3 ndida species including Candida albicans and Candida tropicalis.

4 Neisseria mucosa (1), Escherichia coli (3), Candida tropicalis (1), Propionibacterium (1), and Rothi

5 ow among the isolates of C. albicans (0.4%), Candida tropicalis (1.3%), and Candida parapsilosis (2.1

6 brata (29%), Candida parapsilosis (17%), and Candida tropicalis (10%).

7 14 Candida albicans, 10 Candida glabrata, 10 Candida tropicalis, 10 Candida krusei, 10 Candida dublin

8 %), followed by Candida glabrata (25.6%) and Candida tropicalis (16.3%).

9 parapsilosis, 13.4% Candida glabrata, 10.1% Candida tropicalis, 2.4% Candida krusei, 1.7% Candida gu

10 yeast isolates, including 55 C. albicans, 27 Candida tropicalis, 22 Torulopsis (Candida) glabrata, an

11 tes, including 57 of Candida albicans, 26 of Candida tropicalis, 23 of Candida glabrata, and 27 of ot

12 nt strains of Candida albicans (11 mutants), Candida tropicalis (4 mutants), Candida krusei (3 mutant

13 ilosis (29.4%), Candida glabrata (7.8%), and Candida tropicalis (5.6%).

14 apsilosis (23.7%), Candida glabrata (12.7%), Candida tropicalis (5.8%), Candida krusei (4%), and othe

15 ida glabrata and Candida parapsilosis (15%), Candida tropicalis (9%), and miscellaneous Candida spp.

16 % (95% CI, 98.3%-99.4%) for Candida albicans/Candida tropicalis, 99.3% (95% CI, 98.7%-99.6%) for Cand

17 Yeast (Candida tropicalis) acyl-CoA oxidase catalyzes the oxida

18 In this study we investigate Candida tropicalis, an important human fungal pathogen t

19 charomyces cerevisiae, and 1 isolate each of Candida tropicalis and Candida lusitaniae.

20 Interestingly, Candida tropicalis and the emerging fungal pathogen Cand

21 Candida glabrata, 20 Candida parapsilosis, 9 Candida tropicalis, and 1 each of Candida krusei and Can

22 andida glabrata, 22 Candida parapsilosis, 14 Candida tropicalis, and 8 Candida krusei isolates), as d

23 ans, Candida glabrata, Candida parapsilosis, Candida tropicalis, and Aspergillus fumigatus.

24 ans, Candida glabrata, Candida parapsilosis, Candida tropicalis, and Candida krusei with low error ra

25 , three C. albicans, two Candida krusei, two Candida tropicalis, and one C. parapsilosis isolate; P >

26 ication of Candida albicans, Candida krusei, Candida tropicalis, and perhaps Candida glabrata.

27 Candida albicans and Candida tropicalis are opportunistic fungal pathogens th

28 Candida parapsilosis, Candida glabrata, and Candida tropicalis as well as other clinical species.

29 Candida krusei, Candida guilliermondii, and Candida tropicalis), Aspergillus fumigatus, Scedosporium

30 Candida tropicalis ATCC 750 was not useful for this purp

31 ndida albicans ATCC 24333 and ATCC 76615 and Candida tropicalis ATCC 750, showed a less sharp flucona

32 inst two strains of fungi, Candida kefyr and Candida tropicalis, but were inactive against Candida al

33 Live Candida tropicalis, Candida glabrata, a nongerminating s

34 tly higher error rates were found in CPT for Candida tropicalis, Candida glabrata, and other common p

35 was found in C. albicans serotypes A and B, Candida tropicalis, Candida guilliermondii, Candida glab

36 ed FN is increased only in Candida albicans, Candida tropicalis, Candida krusei, and Candida glabrata

37 Streptococcus sanguis, Streptococcus mutans, Candida tropicalis, Candida parapsilosis, Candida krusei

38 x panel (Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida lusita

39 Both probes reacted with Candida tropicalis DNA, but the T(m) was 51.85 +/- 0.05

40 Candida tropicalis has emerged as the second most freque

41 rapsilosis, and Candida auris and less so in Candida tropicalis infection; acquired echinocandin resi

42 The human fungal pathogen Candida tropicalis is widely distributed in clinical and

43 (19.0%) Candida parapsilosis, and 5 (11.9%) Candida tropicalis isolates and 1 (2.4%) Cryptococcus ne

44 ida albicans, 12 Candida parapsilosis, and 4 Candida tropicalis isolates) were recovered from both sy

45 isolates, 153 Candida glabrata isolates, 70 Candida tropicalis isolates, 36 Candida parapsilosis iso

46 IC(90), 0.03/0.06 mg/L; 100.0% susceptible), Candida tropicalis (MIC(50)/MIC(90), 0.03/0.06 mg/L; 100

47 roup comprised Candida parapsilosis (n = 1), Candida tropicalis (n = 1), Candida ciferrii (n = 1), Ca

48 bicans (n = 161), Candida glabrata (n = 41), Candida tropicalis (n = 35), Candida parapsilosis (n = 2

49 bicans (n = 486), Candida glabrata (n = 96), Candida tropicalis (n = 51), Candida parapsilosis (n = 4

50 (n = 12), Saccharomyces cerevisiae ( n = 9), Candida tropicalis (n = 8), Candida lusitaniae (n = 1),

51 isolates were C. glabrata, two isolates were Candida tropicalis, one isolate was Candida albicans, an

52 CI, 1.18-2.44; P = .001), and infection with Candida tropicalis (OR, 1.64; 95% CI, 1.11-2.39; P = .01

53 DNA sequences but a closely related species, Candida tropicalis, possesses homogenized inverted repea

54 Candida tropicalis produced colonies similar to those of

55 The crystal structure of the Candida tropicalis Stn1N complexed with Ten1 demonstrate

56 uconazole resistance in Candida albicans and Candida tropicalis (those for Candida glabrata were unch

57 The binding of Candida tropicalis to fibronectin (FN) was studied in or

58 greement was lowest for Candida glabrata and Candida tropicalis with both test systems.

59 ins of Candida albicans, Candida kruzei, and Candida tropicalis, with stronger activity observed for

60 ure of the secreted aspartic proteinase from Candida tropicalis yeast (SAPT) has been determined to 1